{
    "title": "Biogen says U.S. FTC, SEC probing Alzheimer's disease drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10478519/Biogen-says-U-S-FTC-SEC-probing-Alzheimers-disease-drug.html",
    "date": "2022-02-04",
    "keywords": [
        "biogen",
        "drug",
        "approval",
        "ftc",
        "commission",
        "information",
        "treatment",
        "filing",
        "sec",
        "panel",
        "health",
        "investigation",
        "plan",
        "reporting",
        "trade",
        "exchange",
        "inc",
        "marketing",
        "drugmaker",
        "report",
        "httpswwwsecgovixdocarchivesedgardata875045000087504522000007biib20211231htm",
        "thursday",
        "demand",
        "subpoena",
        "oversight",
        "industry",
        "competition",
        "consumer",
        "protection",
        "food",
        "administration",
        "june",
        "benefit",
        "expert",
        "july",
        "fda",
        "office",
        "inspector",
        "general",
        "department",
        "price",
        "december",
        "age",
        "group",
        "trial",
        "april",
        "request",
        "comment",
        "raymond",
        "diane",
        "bartz",
        "writing",
        "humer",
        "editing",
        "shinjini",
        "ganguli",
        "cynthia",
        "osterman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}